FDP, UTHR, ESI, AEA, SGMO, MSTR, Expected to Trade Lower After Bearish Insider Trading
June 6, 2011 / M2 PRESSWIRE / BUYINS.NET / http://www.squeezetrigger.com is monitoring top insider trading patterns and these stocks are the most likely to trade Lower in the next 6 months. FRESH DEL MONTE PRODUCE INC (NYSE:FDP), UNITED THERAPEUTICS CORPORATION (NASDAQ:UTHR), ITT EDUCATIONAL SERVICES INC (NYSE:ESI), ADVANCE AMERICA, CASH ADVANCE CENTERS, INC. (NYSE:AEA), SANGAMO BIOSCIENCES, INC. (NASDAQ:SGMO), MICROSTRATEGY INCORPORATED (NASDAQ:MSTR) are all expected to go Lower as Sell signals have been generated by top insider trading patterns. The most important data elements considered when performing insider analysis are: Insiders Track Record - An insiders track record is best summarized by the Insider Score which ranges from 1 (least predictive) to 100 (most predictive) based on prior trading performance. In addition, the actual returns following the insiders prior trades are included to determine the potential magnitude of future returns. Insiders Role - Trades by higher-level insiders are generally more predictive than trades by lower level insiders. Higher-level insiders to include Chairman (CB), Chief Executive Officer (CEO), President (P), Chief Financial Officer (CFO), and Vice Chairman (VC).
The chart below displays the stocks expected to go Lower along with the insider name, position, predictive insider score, 6 month expected return and number of trading decisions included in the score.
Symbol Company Name Insider Name Role Shares Insider Score Avg 6 Month Return # of Dec.
FDP FRESH DEL MONTE PRODUCE INC Abu, Ghazaleh Amir D 89,568 82 -9.7% 13
UTHR UNITED THERAPEUTICS CORPORATION Ferrari, John Maxim CFO 5,500 87 -5.0% 40
ESI ITT EDUCATIONAL SERVICES INC Van, Buren Martin CT 3,000 89 -47.1% 3
AEA ADVANCE AMERICA, CASH ADVANCE CENTERS, INC. Johnson, George D Jr B 167,200 80 -19.0% 8
SGMO SANGAMO BIOSCIENCES, INC. Gregory, Philip D O 15,000 100 -38.3% 20
MSTR MICROSTRATEGY INCORPORATED Saylor, Michael J CEO 40,472 100 -21.7% 66
The insider buying report presents recent insider purchases, reported on Forms 3, 4, and 5 filed with the SEC. The transactions are aggregated to a 'decision' level which simplifies the data analysis. A decision is a grouping of buying or selling by an individual at the specified company.
FRESH DEL MONTE PRODUCE INC (NYSE:FDP) - Fresh Del Monte Produce Inc., together with its subsidiaries, produces, transports, sources, markets, and distributes fresh and fresh-cut fruit and vegetables worldwide. It also offers prepared fruit and vegetables, juices, beverages, and snacks. The company provides various fresh-cut fruit products, including pineapple, melons, grapes, citrus, apples, mango, pears, peaches, plums, nectarines, cherries, apricots, avocados, and kiwi; other fruit products comprising strawberries and plantains; and fresh-cut vegetable products primarily consisting of potatoes, onions, bell peppers, and cucumbers, as well as prepared salads, such as coleslaw and potato salad. In addition, Fresh Del engages in ocean freight; the manufacture of plastics and box products comprising bins, trays, bags, and boxes; growing grains on leased farms, including soybean, wheat, and rice; and the poultry farming businesses, as well as owns and operates grain silos for the storage of grains. The company markets and distributes its products to retail stores, foodservice operators, food clubs, wholesalers, and distributors. It offers its fresh produce under the DEL MONTE, UTC, and Rosy names; and prepared fruits and vegetables, juices, beverages, and snacks under the DEL MONTE, Fruit Express, Just Juice, and Fruitini names. The company was founded in 1886 and is based in George Town, Cayman Islands.
UNITED THERAPEUTICS CORPORATION (NASDAQ:UTHR) - United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of therapeutic products for patients with chronic and life-threatening diseases in the United States and Internationally. It offers Remodulin, Tyvaso, and Adcirca (tadalafil) tablets for the treatment of pulmonary arterial hypertension (PAH); and CardioPAL SAVI and decipher cardiac monitors, and CardioPAL SAVI wireless cardiac event monitors for cardiac arrhythmias and ischemic heart disease. The companys under development products include Oral Treprostinil, which is in Phase III clinical trials for the treatment of PAH and is in Phase II clinical trials for the treatment of peripheral vascular disease; Beraprost-MR, a Phase II clinical trials product for the treatment of PAH; 3F8 MAb, a Phase II clinical trials product for neuroblastoma; Aviptadil, a Phase II clinical trials product targeting pulmonary hypertension and other pulmonary diseases; 8H9 MAb, a Phase I clinical trials product for the treatment of metastatic brain cancer; IW001, a Phase I clinical trials product that targets idiopathic pulmonary fibrosis and primary graft dysfunction; and Glycobiology Antiviral Agents, which are in pre-clinical trials for Hepatitis C and other infectious diseases. United Therapeutics Corporation also provides telemedicine monitoring services to detect cardiac arrhythmias and ischemic heart disease. The company sells its products through sales and marketing staff, specialty pharmaceutical distributors, and pharmaceutical wholesalers. It has a licensing agreements and relationships with Eli Lilly and Company; Toray Industries, Inc.; NEBU-TEC; Mondobiotech; ImmuneWorks; GlaxoSmithKline PLC; Pfizer Inc.; and Supernus Pharmaceuticals, Inc. The company was formerly known as Lung Rx, Inc. and changed its name in December, 1997. United Therapeutics Corporation was founded in 1996 and is headquartered in Silver Spring, Maryland.
ITT EDUCATIONAL SERVICES INC (NYSE:ESI) - itt Educational Services Inc. offers postsecondary-degree programs in the U.S. that provide diplomas as well as associates, bachelors, and masters degrees in information technology, electronics technology, drafting and design, business, criminal justice, and health sciences. As of Mar. 22, the company operated 90 itt Technical Institutes in 33 states that primarily offer career-oriented degree programs to about 47,000 students. Headquartered in Carmel, Ind., itt was started in 1946.
ADVANCE AMERICA, CASH ADVANCE CENTERS, INC. (NYSE:AEA) - Advance America, Cash Advance Centers, Inc. provides cash advance services in the United States, the United Kingdom, and Canada. The company offers cash advance services, which include cash advances, installment loans, and lines of credit. Its cash advances are small-denomination, short-term, and unsecured advances that are due on the customer's next payday. The company also provides check cashing services at state authorized rates; pre-paid debit cards and money orders; and money transmission and bill payment services. It primarily serves middle-income working individuals. As of December 31, 2009, Advance America, Cash Advance Centers, Inc. operated 2,553 centers in the United States under the Advance America and National Cash Advance brand names; and 21 centers in the United Kingdom and 13 centers in Canada under the National Cash Advance brand name. It also had 71 limited licensees in the United Kingdom. The company was founded in 1997 and is headquartered in Spartanburg, South Carolina.
SANGAMO BIOSCIENCES, INC. (NASDAQ:SGMO) - Sangamo Biosciences, Inc. engages in the research, development, and commercialization of zinc finger DNA-binding proteins (ZFPs) for gene regulation and gene modification in the United States. Its ZFPs could be engineered to make ZFP transcription factors (ZFP TFs), proteins that could be used to turn genes on or off; and ZFP nucleases (ZFNs), proteins that enable to modify DNA sequences in various ways. The companys principal ZFP therapeutic include SB-509, a plasmid formulation of a ZFP TF activator of the vascular endothelial growth factor-A (VEGF-A) gene that is in a Phase 2b clinical trial for the treatment of severe diabetic neuropathy; and in a Phase 2 clinical trial in for the treatment of amyotrophic lateral sclerosis, as well as in preclinical animal studies for spinal cord injury, traumatic brain injury, and stroke. It is also developing SB-728-T, a ZFN-modified T-cell product, which is in Phase 1/2 clinical trial and two Phase 1 trials for the treatment of HIV/AIDS. In addition, the company develops SB-313xTZ, a ZFN-based therapeutic that is in Phase 1 clinical trial for the treatment of glioblastoma multiforme, a type of brain cancer. Further, it has preclinical development programs of ZFP therapeutics in the areas of Parkinsons disease, hemophilia B, and neuropathic pain; and neuroregenerative programs in spinal cord injury, traumatic brain injury, and stroke. Additionally, the company has research stage programs in the areas of monogenic diseases and genetic conditions that result from a defect in a single gene, including hemophilia and other hemoglobinopathies, and immunodeficiencies. It has collaboration agreements with Sigma-Aldrich Corporation; Dow AgroSciences LLC; Pfizer Inc.; Genentech, Inc.; Open Monoclonal Technology, Inc.; and F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc. The company was founded in 1995 and is headquartered in Richmond, California.
MICROSTRATEGY INCORPORATED (NASDAQ:MSTR) - MicroStrategy Incorporated provides business intelligence (BI) software worldwide. It offers MicroStrategy 9, an integrated BI platform that enables businesses to make business decisions. The MicroStrategy 9 platform consists of product components, such as Intelligence Server, a foundation for the BI platform; Report Services, an enterprise reporting engine that delivers production and operational reports, managed metrics reports, and interactive dashboards; OLAP Services that allows Web and desktop users to manipulate Intelligent Cubes databases; Web and Web Universal, a browser independent Web interface providing query, reporting, and analysis through a platform independent architecture; Office that lets Microsoft Office users to run, edit, and format MicroStrategy reports directly from within Microsoft applications; and Distribution Services product that controls report and dashboard distribution. The MicroStrategy 9 platforms product components also comprise Desktop, a BI development environment; Architect, whose applications are modeled through an intuitive graphical user interface; SDK for the integration of MicroStrategy 9 features and functionality into any application on multiple platforms; Mobile that offers mobile workers with access to BI reports on their smartphones; Integrity Manager; Command Manager, which automates MicroStrategy administrative tasks; Enterprise Manager that provides prebuilt reports and dashboards; Object Manager; and MultiSource Option that allows users to report, analyze, and monitor data across various data sources. The company also offers technical support, consulting, and education services; and operates Angel.com that provides interactive voice response telephony systems. MicroStrategy Incorporated serves retail, telecommunications, financial services, insurance, healthcare, manufacturing, technology, and government and public services sectors. The company was founded in 1989 and is based in McLean, Virginia.
About BUYINS.NET
BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO
INVESTMENTS & TRADING
SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
Insider Trading tracks all insider trades and selects those insider buys that predict higher moves and insider sales that predict lower moves.
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.
Contact:
BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net